S
LKFT

SignatureFD’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

SignatureFD’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5K Buy
1,852
+241
+15% +$6.84K ﹤0.01% 1807
2026
Q1 		$48.3K Sell
1,611
-30
-2% -$993 ﹤0.01% 1742
2025
Q4 		$53.7K Sell
1,641
-199
-11% -$6.42K ﹤0.01% 1607
2025
Q3 		$63.7K Buy
1,840
+275
+18% +$8.8K ﹤0.01% 1508
2025
Q2 		$43.8K Sell
1,565
-299
-16% -$8.02K ﹤0.01% 1654
2025
Q1 		$46.8K Sell
1,864
-4,972
-73% -$126K ﹤0.01% 1605
2024
Q4 		$188K Buy
6,836
+423
+7% +$11.8K ﹤0.01% 902
2024
Q3 		$185K Buy
6,413
+2,541
+66% +$69.2K ﹤0.01% 907
2024
Q2 		$95.9K Buy
3,872
+1,258
+48% +$35.7K ﹤0.01% 1179
2024
Q1 		$84.2K Buy
2,614
+644
+33% +$23.9K ﹤0.01% 1279
2023
Q4 		$80.1K Buy
1,970
+867
+79% +$31.9K ﹤0.01% 1229
2023
Q3 		$38.1K Buy
1,103
+195
+21% +$7.59K ﹤0.01% 1527
2023
Q2 		$36.9K Buy
908
+279
+44% +$11.4K ﹤0.01% 1583
2023
Q1 		$24.3K Buy
629
+308
+96% +$12.7K ﹤0.01% 1761
2022
Q4 		$14.2K Buy
321
+282
+723% +$11.9K ﹤0.01% 1964
2022
Q3 		$2K Sell
39
-370
-90% -$19K ﹤0.01% 2775
2022
Q2 		$23K Sell
409
-80
-16% -$4.74K ﹤0.01% 1692
2022
Q1 		$30K Sell
489
-16
-3% -$979 ﹤0.01% 1632
2021
Q4 		$28K Buy
505
+264
+110% +$13.8K ﹤0.01% 1620
2021
Q3 		$13K Buy
241
+7
+3% +$416 ﹤0.01% 1939
2021
Q2 		$16K Buy
234
+183
+359% +$14K ﹤0.01% 1803
2021
Q1 		$4K Buy
51
+2
+4% +$184 ﹤0.01% 2234
2020
Q4 		$5K Buy
49
+12
+32% +$1.47K ﹤0.01% 1952
2020
Q3 		$5K Buy
37
+15
+68% +$2.5K ﹤0.01% 1892
2020
Q2 		$4K Sell
22
-19
-46% -$3.94K ﹤0.01% 1882
2020
Q1 		$8K Buy
41
+3
+8% +$645 ﹤0.01% 1543
2019
Q4 		$8K Buy
38
+34
+850% +$6.29K ﹤0.01% 1516
2019
Q3 		$1K Buy
+4
New +$655 ﹤0.01% 1946

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SignatureFD's LKFT Position: Q2 2026 in Review

SignatureFD increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 15% in Q2 2026, buying an estimated $6.84K and bringing the position to 1,852 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

SignatureFD first reported a position in LKFT in Q3 2019 and has held it in 28 quarters since. The position peaked at $188K in Q4 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • SignatureFD held 1,852 shares of Lakefront Biotherapeutics American Depositary Shares worth $55.5K as of Q2 2026.
  • SignatureFD bought 241 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $6.84K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1807 holding.
  • SignatureFD first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 28 quarters since.
  • SignatureFD's Lakefront Biotherapeutics American Depositary Shares position peaked at $188K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.